Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pathophysiol. Aug 15, 2014; 5(3): 188-199
Published online Aug 15, 2014. doi: 10.4291/wjgp.v5.i3.188
Table 3 Radiologic studies of intrahepatic cholangiocarcinoma
Ref.nMethodFindings or conclusion
Nanashima et al[25]42CTFactor for poor prognosis: case showing arterial enhancement with lower attenuation
Kim et al[26]20MRI6 (30%) of the 20 cases appeared as hypervascular lesions with washout on delayed phase
Kang et al[27]50MRIPercentage of relative enhancement on hepatobiliary phase was significantly higher in moderately differentiated tumors than in poorly differentiated tumors and in patients without than in those with lymph node metastasis
Xu et al[28]40Contrast enhanced ultrasono-graphyMF-type (n = 32): (1) peripheral rim-like hyperenhancement (n = 19); (2) heterogenous enhancement (n = 10); and (3) homogenous hyperenhancement (n = 3)
Ariizumi et al[29]26FDG PETPI-type (n = 4): heterogenous enhancement (n = 4) IG-type (n = 4): (1) homogenous hyperenhancement (n = 3); and (2) heterogenous enhancement (n = 1) FDG PET was able to predict patient outcome after radioembolization treatment